Biotechblog – Page 1058 – Biotechnology business, policy, and more!

Amgen’s patents protect Epogen. Again.

Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal […]

The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last

The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last

Welcome to the second August 2007 edition of Carnival of Biotechnology. International Biotechnology The Times (UK) has a report on

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to

I’m in the final stages of preparing a book on best practices in biotechnology business development, and am looking for

Welcome to the August 2007 edition of Carnival of Biotechnology. Industry Trends Singapore-based ES Cell International, the company that was

Guest content Contributed by Jayme Norrie, Chief Strategic Officer, Incite World From what we have experienced, angel investors are shoring

Guest content contributed by Agnes Shanley, Editor in Chief, Pharmaceutical Manufacturing Every day we read about severe shortages of skilled

A guest editorial from Emil Ciurczak, Contributing Editor, PharmaManufacturing.com While reading a trade magazine recently, I was struck with the